Abstract
Purpose
We sought to determine the utility of noninvasive color-flow duplex imaging (CDI) in the detection of iliac artery stenoses or occlusions and correlate the findings of long-term color flow duplex surveillance (CFDS) to clinical outcome after percutaneous iliac interventions.
Methods
All patients undergoing percutaneous iliac angioplasty and stenting are prospectively entered in a surveillance protocol with CFDS and ankle-brachial indices (ABIs) performed within 6 weeks, 6 months, 12 months, and every year thereafter. Preprocedural ABI and peak systolic velocity (PSV) values were compared with postprocedural values with the Student t-test. Kaplan-Meier life-table analysis was used to estimate the patency rates.
Results
During the last 4 years, 80 patients with 112 treated iliac systems fulfilled the study criteria. A total of 68 patients (84%) had claudication, 8 (10%) had pain at rest, and 5 (6%) had a nonhealing ulcer or gangrene. The procedural success rate was 96.4%. Comparison of ABIs and PSV values before and after iliac intervention was statistically significant (p < 0.0001). Duplex scan allowed the detection and/or monitoring of abnormal velocities in 14 treated iliac arteries. Four cases (3.5%) required reintervention on previously treated iliac arteries for symptomatic restenosis and/or disease progression. Late stent occlusions were correctly identified in two cases. Primary patency, assisted primary patency, and secondary patency rates were 77%, 94%, and 96% at 4 years, respectively.
Conclusion
CFDS allows the detection of iliac artery stenoses and is a useful tool to identify restenosis after intervention. Because of the overall excellent patency rates observed with iliac angioplasty and stenting, CFDS surveillance in the absence of symptoms may not always be necessary and its long-term use should be individualized.
Get full access to this article
View all access options for this article.